{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T12:28:10Z","timestamp":1793363290265,"version":"4.5.0"},"reference-count":97,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,23]],"date-time":"2019-07-23T00:00:00Z","timestamp":1563840000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,7,23]],"date-time":"2019-07-23T00:00:00Z","timestamp":1563840000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12967-019-1993-1","type":"journal-article","created":{"date-parts":[[2019,7,23]],"date-time":"2019-07-23T14:15:33Z","timestamp":1563891333000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":120,"title":["Wolfram syndrome, a rare neurodegenerative disease: from pathogenesis to future treatment perspectives"],"prefix":"10.1186","volume":"17","author":[{"given":"Maria Teresa","family":"Pallotta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Tascini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Crispoldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciriana","family":"Orabona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giada","family":"Mondanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula","family":"Grohmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4103-2837","authenticated-orcid":false,"given":"Susanna","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,23]]},"reference":[{"issue":"1","key":"1993_CR1","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s11892-015-0702-6","volume":"16","author":"F Urano","year":"2016","unstructured":"Urano F. Wolfram syndrome: diagnosis, management, and treatment. Curr Diabetes Rep. 2016;16(1):6.","journal-title":"Curr Diabetes Rep"},{"key":"1993_CR2","first-page":"715","volume":"13","author":"DJ Wolfram","year":"1938","unstructured":"Wolfram DJ. Diabetes mellitus and simple optic atrophy among siblings. Mayo Clin Proc. 1938;13:715\u20138.","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"1993_CR3","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/2441","volume":"20","author":"H Inoue","year":"1998","unstructured":"Inoue H, Tanizawa Y, Wasson J, Behn P, Kalidas K, Bernal-Mizrachi E, et al. A gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy (Wolfram syndrome). Nat Genet. 1998;20(2):143.","journal-title":"Nat Genet"},{"issue":"4","key":"1993_CR4","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1086\/520961","volume":"81","author":"S Amr","year":"2007","unstructured":"Amr S, Heisey C, Zhang M, Xia X-J, Shows KH, Ajlouni K, et al. A homozygous mutation in a novel zinc-finger protein, ERIS, is responsible for Wolfram syndrome 2. Am J Hum Genet. 2007;81(4):673\u201383.","journal-title":"Am J Hum Genet"},{"issue":"5","key":"1993_CR5","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1038\/pr.2018.17","volume":"83","author":"L Rigoli","year":"2018","unstructured":"Rigoli L, Bramanti P, Di Bella C, De Luca F. Genetic and clinical aspects of Wolfram syndrome 1, a severe neurodegenerative disease. Pediatr Res. 2018;83(5):921\u20139.","journal-title":"Pediatr Res"},{"issue":"7","key":"1993_CR6","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1002\/humu.23233","volume":"38","author":"D Astuti","year":"2017","unstructured":"Astuti D, Sabir A, Fulton P, Zatyka M, Williams D, Hardy C, et al. Monogenic diabetes syndromes: locus-specific databases for Alstr\u00f6m, Wolfram, and Thiamine-responsive megaloblastic anemia. Hum Mutat. 2017;38(7):764\u201377.","journal-title":"Hum Mutat"},{"issue":"1","key":"1993_CR7","doi-asserted-by":"publisher","first-page":"e000081","DOI":"10.1136\/bmjophth-2017-000081","volume":"3","author":"J Hoekel","year":"2018","unstructured":"Hoekel J, Narayanan A, Rutlin J, Lugar H, Al-Lozi A, Hershey T, et al. Visual pathway function and structure in Wolfram syndrome: patient age, variation and progression. BMJ Open Ophthalmol. 2018;3(1):e000081.","journal-title":"BMJ Open Ophthalmol"},{"issue":"12","key":"1993_CR8","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1038\/sj.ejhg.5201491","volume":"13","author":"L Hansen","year":"2005","unstructured":"Hansen L, Eiberg H, Barrett T, Bek T, Kjaersgaard P, Tranebjaerg L, et al. Mutation analysis of the WFS1 gene in seven Danish Wolfram syndrome families; four new mutations identified. Eur J Hum Genet. 2005;13(12):1275\u201384.","journal-title":"Eur J Hum Genet"},{"issue":"5","key":"1993_CR9","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1136\/jmg.2005.034892","volume":"43","author":"H Eiberg","year":"2006","unstructured":"Eiberg H, Hansen L, Kjer B, Hansen T, Pedersen O, Bille M, Rosenberg T, et al. Autosomal dominant optic atrophy associated with hearing impairment and impaired glucose regulation caused by a missense mutation in the WFS1 gene. J Med Genet. 2006;43(5):435\u201340.","journal-title":"J Med Genet"},{"issue":"6","key":"1993_CR10","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1002\/ajmg.a.33970","volume":"155A","author":"ND Rendtorff","year":"2011","unstructured":"Rendtorff ND, Lodahl M, Boulahbel H, Johansen IR, Pandya A, Welch KO, et al. Identification of p.A684V missense mutation in the WFS1 gene as a frequent cause of autosomal dominant optic atrophy and hearing impairment. Am J Med Genet A. 2011;155A(6):1298\u2013313.","journal-title":"Am J Med Genet A"},{"issue":"8988","key":"1993_CR11","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1016\/S0140-6736(95)92473-6","volume":"346","author":"TG Barrett","year":"1995","unstructured":"Barrett TG, Bundey SE, Macleod AF. Neurodegeneration and diabetes: UK nationwide study of Wolfram (DIDMOAD) syndrome. Lancet. 1995;346(8988):1458\u201363.","journal-title":"Lancet"},{"issue":"1","key":"1993_CR12","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/j.1399-5448.2009.00518.x","volume":"11","author":"S Kumar","year":"2010","unstructured":"Kumar S. Wolfram syndrome: important implications for pediatricians and pediatric endocrinologists. Pediatr Diabetes. 2010;11(1):28\u201337.","journal-title":"Pediatr Diabetes"},{"issue":"9","key":"1993_CR13","doi-asserted-by":"publisher","first-page":"e106906","DOI":"10.1371\/journal.pone.0106906","volume":"9","author":"K Matsunaga","year":"2014","unstructured":"Matsunaga K, Tanabe K, Inoue H, Okuya S, Ohta Y, Akiyama M, et al. Wolfram syndrome in the Japanese population; molecular analysis of WFS1 gene and characterization of clinical features. PLoS ONE. 2014;9(9):e106906.","journal-title":"PLoS ONE"},{"issue":"3","key":"1993_CR14","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1136\/jmg.14.3.190","volume":"14","author":"FC Fraser","year":"1977","unstructured":"Fraser FC, Gunn T. Diabetes mellitus, diabetes insipidus, and optic atrophy. An autosomal recessive syndrome? J Med Genet. 1977;14(3):190\u20133.","journal-title":"J Med Genet"},{"issue":"4","key":"1993_CR15","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1210\/jc.2002-030015","volume":"89","author":"R Medlej","year":"2004","unstructured":"Medlej R, Wasson J, Baz P, Azar S, Salti I, Loiselet J, et al. Diabetes mellitus and optic atrophy: a study of Wolfram syndrome in the Lebanese population. J Clin Endocrinol Metab. 2004;89(4):1656\u201361.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1993_CR16","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s40618-013-0039-4","volume":"37","author":"F Lombardo","year":"2014","unstructured":"Lombardo F, Salzano G, Di Bella C, Aversa T, Pugliatti F, Cara S, et al. Phenotypical and genotypical expression of Wolfram syndrome in 12 patients from a Sicilian district where this syndrome might not be so infrequent as generally expected. J Endocrinol Invest. 2014;37(2):195\u2013202.","journal-title":"J Endocrinol Invest"},{"issue":"10","key":"1993_CR17","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1136\/jmg.34.10.838","volume":"34","author":"TG Barrett","year":"1997","unstructured":"Barrett TG, Bundey SE. Wolfram (DIDMOAD) syndrome. J Med Genet. 1997;34(10):838\u201341.","journal-title":"J Med Genet"},{"issue":"3","key":"1993_CR18","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1172\/JCI39678","volume":"120","author":"SG Fonseca","year":"2010","unstructured":"Fonseca SG, Ishigaki S, Oslowski CM, Lu S, Lipson KL, Ghosh R, et al. Wolfram syndrome 1 gene negatively regulates ER stress signaling in rodent and human cells. J Clin Invest. 2010;120(3):744\u201355.","journal-title":"J Clin Invest"},{"issue":"2","key":"1993_CR19","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s12020-010-9350-4","volume":"38","author":"G Yu","year":"2010","unstructured":"Yu G, Yu M, Wang J, Gao C, Chen Z. WS1 gene mutation analysis of Wolfram syndrome in a Chinese patient and a systematic review of literatures. Endocrine. 2010;38(2):147\u201352.","journal-title":"Endocrine"},{"issue":"13","key":"1993_CR20","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1093\/hmg\/7.13.2021","volume":"7","author":"TM Strom","year":"1998","unstructured":"Strom TM, H\u00f6rtnagel K, Hofmann S, Gekeler F, Scharfe C, Rabl W, et al. Diabetes insipidus, diabetes mellitus, optic atrophy and deafness (DIDMOAD) caused by mutations in a novel gene (wolframin) coding for a predicted transmembrane protein. Hum Mol Genet. 1998;7(13):2021\u20138.","journal-title":"Hum Mol Genet"},{"issue":"8","key":"1993_CR21","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.2337\/diacare.27.8.2003","volume":"27","author":"CJA Smith","year":"2004","unstructured":"Smith CJA, Crock PA, King BR, Meldrum CJ, Scott RJ. Phenotype-genotype correlations in a series of wolfram syndrome families. Diabetes Care. 2004;27(8):2003\u20139.","journal-title":"Diabetes Care"},{"issue":"2","key":"1993_CR22","doi-asserted-by":"publisher","first-page":"382","DOI":"10.3390\/ijms18020382","volume":"18","author":"D Ariyasu","year":"2017","unstructured":"Ariyasu D, Yoshida H, Hasegawa Y. Endoplasmic reticulum (ER) stress and endocrine disorders. Int J Mol Sci. 2017;18(2):382.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"1993_CR23","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/gim.2012.180","volume":"15","author":"ML de Heredia","year":"2013","unstructured":"de Heredia ML, Cleries R, Nunes V. Genotypic classification of patients with Wolfram syndrome: insights into the natural history of the disease and correlation with phenotype. Genet Med. 2013;15(7):497\u2013506.","journal-title":"Genet Med"},{"key":"1993_CR24","unstructured":"Tranebj\u00e6rg L, Barrett T, Rendtorff ND. WFS1-related disorders; 2013."},{"issue":"4","key":"1993_CR25","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1001\/archotol.129.4.411","volume":"129","author":"MM Lesperance","year":"2003","unstructured":"Lesperance MM, Hall JW, San Agustin TB, Leal SM. Mutations in the Wolfram syndrome type 1 gene (WFS1) define a clinical entity of dominant low-frequency sensorineural hearing loss. Arch Otolaryngol Neck Surg. 2003;129(4):411\u201320.","journal-title":"Arch Otolaryngol Neck Surg"},{"issue":"2","key":"1993_CR26","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/j.1399-0004.2010.01522.x","volume":"79","author":"L Rigoli","year":"2011","unstructured":"Rigoli L, Lombardo F, Di Bella C. Wolfram syndrome and WFS1 gene. Clin Genet. 2011;79(2):103\u201317.","journal-title":"Clin Genet"},{"issue":"9","key":"1993_CR27","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1093\/hmg\/ddx060","volume":"26","author":"C Rouzier","year":"2017","unstructured":"Rouzier C, Moore D, Delorme C, Lacas-Gervais S, Ait-El-Mkadem S, Fragaki K, et al. A novel CISD2 mutation associated with a classical Wolfram syndrome phenotype alters Ca2+ homeostasis and ER-mitochondria interactions. Hum Mol Genet. 2017;26(9):1599\u2013611.","journal-title":"Hum Mol Genet"},{"key":"1993_CR28","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/9412676","author":"NB Toppings","year":"2018","unstructured":"Toppings NB, McMillan JM, Au PYB, Suchowersky O, Donovan LE. Wolfram syndrome: a case report and review of clinical manifestations, genetics pathophysiology, and potential therapies. Case Rep Endocrinol. 2018. \n                    https:\/\/doi.org\/10.1155\/2018\/9412676\n                    \n                  .","journal-title":"Case Rep Endocrinol"},{"key":"1993_CR29","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/dom.13379","volume":"20","author":"Y Riahi","year":"2018","unstructured":"Riahi Y, Israeli T, Cerasi E, Leibowitz G. Effects of proinsulin misfolding on \u03b2-cell dynamics, differentiation and function in diabetes. Diabetes Obes Metab. 2018;20:95\u2013103.","journal-title":"Diabetes Obes Metab"},{"issue":"8","key":"1993_CR30","first-page":"705","volume":"41","author":"J-S So","year":"2018","unstructured":"So J-S. Roles of endoplasmic reticulum stress in immune responses. Mol Cells. 2018;41(8):705.","journal-title":"Mol Cells"},{"issue":"6051","key":"1993_CR31","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1126\/science.1209126","volume":"333","author":"BM Gardner","year":"2011","unstructured":"Gardner BM, Walter P. Unfolded proteins are Ire1-activating ligands that directly induce the unfolded protein response. Science. 2011;333(6051):1891\u20134. \n                    https:\/\/doi.org\/10.1126\/science.1209126\n                    \n                  .","journal-title":"Science"},{"issue":"12","key":"1993_CR32","doi-asserted-by":"publisher","first-page":"3028","DOI":"10.1002\/j.1460-2075.1996.tb00666.x","volume":"15","author":"CE Shamu","year":"1996","unstructured":"Shamu CE, Walter P. Oligomerization and phosphorylation of the Ire1p kinase during intracellular signaling from the endoplasmic reticulum to the nucleus. EMBO J. 1996;15(12):3028\u201339.","journal-title":"EMBO J"},{"issue":"2","key":"1993_CR33","doi-asserted-by":"publisher","first-page":"e1648","DOI":"10.1371\/journal.pone.0001648","volume":"3","author":"KL Lipson","year":"2008","unstructured":"Lipson KL, Ghosh R, Urano F. The role of IRE1\u03b1 in the degradation of insulin mRNA in pancreatic \u03b2-cells. PLoS ONE. 2008;3(2):e1648.","journal-title":"PLoS ONE"},{"issue":"2","key":"1993_CR34","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.ceb.2010.11.005","volume":"23","author":"CM Oslowski","year":"2011","unstructured":"Oslowski CM, Urano F. The binary switch that controls the life and death decisions of ER stressed \u03b2 cells. Curr Opin Cell Biol. 2011;23(2):207\u201315.","journal-title":"Curr Opin Cell Biol"},{"issue":"3","key":"1993_CR35","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/S1097-2765(03)00105-9","volume":"11","author":"HP Harding","year":"2003","unstructured":"Harding HP, Zhang Y, Zeng H, Novoa I, Lu PD, Calfon M, et al. An integrated stress response regulates amino acid metabolism and resistance to oxidative stress. Mol Cell. 2003;11(3):619\u201333.","journal-title":"Mol Cell"},{"issue":"11","key":"1993_CR36","doi-asserted-by":"publisher","first-page":"3787","DOI":"10.1091\/mbc.10.11.3787","volume":"10","author":"K Haze","year":"1999","unstructured":"Haze K, Yoshida H, Yanagi H, Yura T, Mori K. Mammalian transcription factor ATF6 is synthesized as a transmembrane protein and activated by proteolysis in response to endoplasmic reticulum stress. Mol Biol Cell. 1999;10(11):3787\u201399.","journal-title":"Mol Biol Cell"},{"issue":"8","key":"1993_CR37","doi-asserted-by":"publisher","first-page":"3832","DOI":"10.1210\/en.2008-0015","volume":"149","author":"H-Y Seo","year":"2008","unstructured":"Seo H-Y, Kim YD, Lee K-M, Min A-K, Kim M-K, Kim H-S, et al. Endoplasmic reticulum stress-induced activation of activating transcription factor 6 decreases insulin gene expression via up-regulation of orphan nuclear receptor small heterodimer partner. Endocrinology. 2008;149(8):3832\u201341.","journal-title":"Endocrinology"},{"issue":"3","key":"1993_CR38","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.cmet.2006.07.007","volume":"4","author":"KL Lipson","year":"2006","unstructured":"Lipson KL, Fonseca SG, Ishigaki S, Nguyen LX, Foss E, Bortell R, et al. Regulation of insulin biosynthesis in pancreatic beta cells by an endoplasmic reticulum-resident protein kinase IRE1. Cell Metab. 2006;4(3):245\u201354.","journal-title":"Cell Metab"},{"issue":"6","key":"1993_CR39","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.coph.2009.07.003","volume":"9","author":"SG Fonseca","year":"2009","unstructured":"Fonseca SG, Burcin M, Gromada J, Urano F. Endoplasmic reticulum stress in \u03b2-cells and development of diabetes. Curr Opin Pharmacol. 2009;9(6):763\u201370.","journal-title":"Curr Opin Pharmacol"},{"issue":"47","key":"1993_CR40","doi-asserted-by":"publisher","first-page":"39609","DOI":"10.1074\/jbc.M507426200","volume":"280","author":"SG Fonseca","year":"2005","unstructured":"Fonseca SG, Fukuma M, Lipson KL, Nguyen LX, Allen JR, Oka Y, et al. WFS1 is a novel component of the unfolded protein response and maintains homeostasis of the endoplasmic reticulum in pancreatic \u03b2-cells. J Biol Chem. 2005;280(47):39609\u201315.","journal-title":"J Biol Chem"},{"issue":"23","key":"1993_CR41","doi-asserted-by":"publisher","first-page":"16016","DOI":"10.1074\/jbc.M601299200","volume":"281","author":"Y Tan","year":"2006","unstructured":"Tan Y, Dourdin N, Wu C, De Veyra T, Elce JS, Greer PA. Ubiquitous calpains promote caspase-12 and JNK activation during endoplasmic reticulum stress-induced apoptosis. J Biol Chem. 2006;281(23):16016\u201324.","journal-title":"J Biol Chem"},{"issue":"49","key":"1993_CR42","doi-asserted-by":"publisher","first-page":"E5292","DOI":"10.1073\/pnas.1421055111","volume":"111","author":"S Lu","year":"2014","unstructured":"Lu S, Kanekura K, Hara T, Mahadevan J, Spears LD, Oslowski CM, et al. A calcium-dependent protease as a potential therapeutic target for Wolfram syndrome. Proc Natl Acad Sci. 2014;111(49):E5292\u2013301.","journal-title":"Proc Natl Acad Sci"},{"issue":"24","key":"1993_CR43","doi-asserted-by":"publisher","first-page":"5635","DOI":"10.1016\/j.febslet.2006.09.007","volume":"580","author":"D Takei","year":"2006","unstructured":"Takei D, Ishihara H, Yamaguchi S, Yamada T, Tamura A, Katagiri H, et al. WFS1 protein modulates the free Ca2+ concentration in the endoplasmic reticulum. FEBS Lett. 2006;580(24):5635\u201340.","journal-title":"FEBS Lett"},{"issue":"2","key":"1993_CR44","doi-asserted-by":"publisher","first-page":"452","DOI":"10.2337\/diabetes.54.2.452","volume":"54","author":"AK Cardozo","year":"2005","unstructured":"Cardozo AK, Ortis F, Storling J, Feng Y-M, Rasschaert J, Tonnesen M, et al. Cytokines downregulate the sarcoendoplasmic reticulum pump Ca2+ ATPase 2b and deplete endoplasmic reticulum Ca2+, leading to induction of endoplasmic reticulum stress in pancreatic \u03b2-cells. Diabetes. 2005;54(2):452\u201361.","journal-title":"Diabetes"},{"issue":"3","key":"1993_CR45","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1093\/hmg\/ddu499","volume":"24","author":"M Zatyka","year":"2014","unstructured":"Zatyka M, Da Silva Xavier G, Bellomo EA, Leadbeater W, Astuti D, Smith J, et al. Sarco (endo) plasmic reticulum ATPase is a molecular partner of Wolfram syndrome 1 protein, which negatively regulates its expression. Hum Mol Genet. 2014;24(3):814\u201327.","journal-title":"Hum Mol Genet"},{"issue":"7","key":"1993_CR46","doi-asserted-by":"publisher","first-page":"e1002511","DOI":"10.1371\/journal.pbio.1002511","volume":"14","author":"M Cagalinec","year":"2016","unstructured":"Cagalinec M, Liiv M, Hodurova Z, Hickey MA, Vaarmann A, Mandel M, et al. Role of mitochondrial dynamics in neuronal development: mechanism for Wolfram syndrome. PLoS Biol. 2016;14(7):e1002511.","journal-title":"PLoS Biol"},{"issue":"2","key":"1993_CR47","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.gene.2012.10.023","volume":"526","author":"L Rigoli","year":"2013","unstructured":"Rigoli L, Lombardo F, Salzano G, Di Bella C, Messina MF, De Luca F, et al. Identification of one novel causative mutation in exon 4 of WFS1 gene in two Italian siblings with classical DIDMOAD syndrome phenotype. Gene. 2013;526(2):487\u20139.","journal-title":"Gene"},{"issue":"3","key":"1993_CR48","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1002\/ana.22160","volume":"69","author":"A Chaussenot","year":"2011","unstructured":"Chaussenot A, Bannwarth S, Rouzier C, Vialettes B, El Mkadem SA, Chabrol B, et al. Neurologic features and genotype-phenotype correlation in Wolfram syndrome. Ann Neurol. 2011;69(3):501\u20138.","journal-title":"Ann Neurol"},{"issue":"1","key":"1993_CR49","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1515\/JPEM.2009.22.1.3","volume":"22","author":"MA Ganie","year":"2009","unstructured":"Ganie MA, Bhat D. Current developments in Wolfram syndrome. J Pediatr Endocrinol Metab. 2009;22(1):3\u201310.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"9","key":"1993_CR50","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.2337\/dc07-0380","volume":"30","author":"A Cano","year":"2007","unstructured":"Cano A, Molines L, Valero R, Simonin G, Paquis-Flucklinger V, Vialettes B. Microvascular diabetes complications in Wolfram syndrome (diabetes insipidus, diabetes mellitus, optic atrophy, and deafness [DIDMOAD]): an age- and duration-matched comparison with common type 1 diabetes. Diabetes Care. 2007;30(9):2327\u201330.","journal-title":"Diabetes Care"},{"issue":"5","key":"1993_CR51","doi-asserted-by":"publisher","first-page":"461.e1","DOI":"10.1016\/j.jaapos.2014.07.162","volume":"18","author":"J Hoekel","year":"2014","unstructured":"Hoekel J, Chisholm SA, Al-Lozi A, Hershey T, Tychsen L. Ophthalmologic correlates of disease severity in children and adolescents with Wolfram syndrome. J Am Assoc Pediatr Ophthalmol Strabismus. 2014;18(5):461.e1\u2013465.e1.","journal-title":"J Am Assoc Pediatr Ophthalmol Strabismus"},{"issue":"1","key":"1993_CR52","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/S0008-4182(06)80064-5","volume":"41","author":"MS Dhalla","year":"2006","unstructured":"Dhalla MS, Desai UR, Zuckerbrod DS. Pigmentary maculopathy in a patient with Wolfram syndrome. Can J Ophthalmol. 2006;41(1):38\u201340.","journal-title":"Can J Ophthalmol"},{"key":"1993_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1651-2227.1977.tb15069.x","volume":"264","author":"CW Cremers","year":"1977","unstructured":"Cremers CW, Wijdeveld PG, Pinckers AJ. Juvenile diabetes mellitus, optic atrophy, hearing loss, diabetes insipidus, atonia of the urinary tract and bladder, and other abnormalities (Wolfram syndrome). A review of 88 cases from the literature with personal observations on 3 new patients. Acta Paediatr Scand Suppl. 1977;264:1\u201316.","journal-title":"Acta Paediatr Scand Suppl"},{"issue":"4","key":"1993_CR54","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0022-3476(76)80387-3","volume":"89","author":"T Gunn","year":"1976","unstructured":"Gunn T, Bortolussi R, Little JM, Andermann F, Fraser FC, Belmonte MM. Juvenile diabetes mellitus, optic atrophy, sensory nerve deafness, and diabetes insipidus\u2014a syndrome. J Pediatr. 1976;89(4):565\u201370.","journal-title":"J Pediatr"},{"issue":"4","key":"1993_CR55","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3109\/13816810.2012.755631","volume":"34","author":"O Chacon-Camacho","year":"2013","unstructured":"Chacon-Camacho O, Arce-Gonzalez R, Granillo-Alvarez M, Flores-Limas S, Ramirez M, Zenteno JC. Expansion of the clinical ocular spectrum of Wolfram syndrome in a family carrying a novel WFS1 gene deletion. Ophthalmic Genet. 2013;34(4):243\u20138.","journal-title":"Ophthalmic Genet"},{"issue":"3","key":"1993_CR56","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1111\/dmcn.14040","volume":"61","author":"A Zmyslowska","year":"2018","unstructured":"Zmyslowska A, Waszczykowska A, Baranska D, Stawiski K, Borowiec M, Jurowski P, et al. Optical coherence tomography and magnetic resonance imaging visual pathway evaluation in Wolfram syndrome. Dev Med Child Neurol. 2018;61(3):359\u201365.","journal-title":"Dev Med Child Neurol"},{"issue":"1","key":"1993_CR57","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1159\/000074187","volume":"9","author":"RJE Pennings","year":"2004","unstructured":"Pennings RJE, Huygen PLM, van den Ouweland JMW, Cryns K, Dikkeschei LD, Van Camp G, et al. Sex-related hearing impairment in Wolfram syndrome patients identified by inactivating WFS1 mutations. Audiol Neurootol. 2004;9(1):51\u201362.","journal-title":"Audiol Neurootol"},{"issue":"1","key":"1993_CR58","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s13023-018-0852-0","volume":"13","author":"R Karzon","year":"2018","unstructured":"Karzon R, Narayanan A, Chen L, Lieu JEC, Hershey T. Longitudinal hearing loss in Wolfram syndrome. Orphanet J Rare Dis. 2018;13(1):102.","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"1993_CR59","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1111\/cge.12437","volume":"87","author":"A Chaussenot","year":"2015","unstructured":"Chaussenot A, Rouzier C, Quere M, Plutino M, Ait-El-Mkadem S, Bannwarth S, et al. Mutation update and uncommon phenotypes in a French cohort of 96 patients with WFS1-related disorders. Clin Genet. 2015;87(5):430\u20139.","journal-title":"Clin Genet"},{"issue":"4","key":"1993_CR60","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1002\/ajmg.b.32157","volume":"162B","author":"R Kovacs-Nagy","year":"2013","unstructured":"Kovacs-Nagy R, Elek Z, Szekely A, Nanasi T, Sasvari-Szekely M, Ronai Z. Association of aggression with a novel microRNA binding site polymorphism in the wolframin gene. Am J Med Genet B Neuropsychiatr Genet. 2013;162B(4):404\u201312.","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"1993_CR61","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2018-225839","author":"S Lodha","year":"2018","unstructured":"Lodha S, Das L, das Ramchandani G, Bhansali A. A case of young diabetes and parasuicide. BMJ Case Rep. 2018. \n                    https:\/\/doi.org\/10.1136\/bcr-2018-225839\n                    \n                  .","journal-title":"BMJ Case Rep"},{"issue":"1","key":"1993_CR62","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ejmg.2011.08.005","volume":"55","author":"SA Yuca","year":"2012","unstructured":"Yuca SA, Rendtorff ND, Boulahbel H, Lodahl M, Tranebj\u00e6rg L, Cesur Y, et al. Rapidly progressive renal disease as part of Wolfram syndrome in a large inbred Turkish family due to a novel WFS1 mutation (p.Leu511Pro). Eur J Med Genet. 2012;55(1):37\u201342.","journal-title":"Eur J Med Genet"},{"issue":"1","key":"1993_CR63","first-page":"53","volume":"11","author":"MA Hasan","year":"2000","unstructured":"Hasan MA, Hazza I, Najada A. Wolfram\u2019s (DIDMOAD) syndrome and chronic renal failure. Saudi J Kidney Dis Transpl. 2000;11(1):53\u20138.","journal-title":"Saudi J Kidney Dis Transpl"},{"issue":"4","key":"1993_CR64","first-page":"548","volume":"19","author":"MC Lim","year":"1990","unstructured":"Lim MC, Thai AC. A Chinese family with Wolfram syndrome presenting with rapidly progressing diabetic retinopathy and renal failure. Ann Acad Med Singap. 1990;19(4):548\u201355.","journal-title":"Ann Acad Med Singap"},{"issue":"3","key":"1993_CR65","doi-asserted-by":"publisher","first-page":"166","DOI":"10.6065\/apem.2018.23.3.166","volume":"23","author":"HA Korkmaz","year":"2018","unstructured":"Korkmaz HA. A case of Wolfram syndrome with chronic renal failure. Ann Pediatr Endocrinol Metab. 2018;23(3):166\u20137.","journal-title":"Ann Pediatr Endocrinol Metab"},{"issue":"1","key":"1993_CR66","doi-asserted-by":"publisher","first-page":"e29150","DOI":"10.1371\/journal.pone.0029150","volume":"7","author":"C Aloi","year":"2012","unstructured":"Aloi C, Salina A, Pasquali L, Lugani F, Perri K, Russo C, et al. Wolfram syndrome: new mutations, different phenotype. PLoS ONE. 2012;7(1):e29150. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0029150\n                    \n                  .","journal-title":"PLoS ONE"},{"issue":"12","key":"1993_CR67","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.2337\/diacare.18.12.1566","volume":"18","author":"BT Kinsley","year":"1995","unstructured":"Kinsley BT, Swift M, Dumont RH, Swift RG. Morbidity and mortality in the Wolfram syndrome. Diabetes Care. 1995;18(12):1566\u201370.","journal-title":"Diabetes Care"},{"issue":"01","key":"1993_CR68","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1055\/s-0033-1357160","volume":"122","author":"A Zmyslowska","year":"2014","unstructured":"Zmyslowska A, Borowiec M, Fichna P, Iwaniszewska B, Majkowska L, Pietrzak I, et al. Delayed recognition of Wolfram syndrome frequently misdiagnosed as type 1 diabetes with early chronic complications. Exp Clin Endocrinol Diabetes. 2014;122(01):35\u20138.","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"211","key":"1993_CR69","doi-asserted-by":"publisher","first-page":"211ra156","DOI":"10.1126\/scitranslmed.3006534","volume":"5","author":"F Engin","year":"2013","unstructured":"Engin F, Yermalovich A, Nguyen T, Hummasti S, Fu W, Eizirik DL, et al. Restoration of the unfolded protein response in pancreatic beta cells protects mice against type 1 diabetes. Sci Transl Med. 2013;5(211):211ra156. \n                    https:\/\/doi.org\/10.1126\/scitranslmed.3006534\n                    \n                  .","journal-title":"Sci Transl Med"},{"issue":"6","key":"1993_CR70","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.ceca.2011.08.005","volume":"50","author":"JW Ramadan","year":"2011","unstructured":"Ramadan JW, Steiner SR, O\u2019Neill CM, Nunemaker CS. The central role of calcium in the effects of cytokines on beta-cell function: implications for type 1 and type 2 diabetes. Cell Calcium. 2011;50(6):481\u201390. \n                    https:\/\/doi.org\/10.1016\/j.ceca.2011.08.005\n                    \n                  .","journal-title":"Cell Calcium"},{"issue":"3","key":"1993_CR71","doi-asserted-by":"publisher","first-page":"923","DOI":"10.2337\/db13-0717","volume":"63","author":"L Shang","year":"2014","unstructured":"Shang L, Hua H, Foo K, Martinez H, Watanabe K, Zimmer M, et al. beta-cell dysfunction due to increased ER stress in a stem cell model of Wolfram syndrome. Diabetes. 2014;63(3):923\u201333.","journal-title":"Diabetes"},{"issue":"4","key":"1993_CR72","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/j.1365-2044.2004.03658.x","volume":"59","author":"T Krause","year":"2004","unstructured":"Krause T, Gerbershagen MU, Fiege M, Weisshorn R, Wappler F. Dantrolene\u2013a review of its pharmacology, therapeutic use and new developments. Anaesthesia. 2004;59(4):364\u201373.","journal-title":"Anaesthesia"},{"issue":"9","key":"1993_CR73","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1212\/WNL.40.9.1427","volume":"40","author":"CH Chan","year":"1990","unstructured":"Chan CH. Dantrolene sodium and hepatic injury. Neurology. 1990;40(9):1427.","journal-title":"Neurology"},{"issue":"9","key":"1993_CR74","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/j.apmr.2011.04.012","volume":"92","author":"JY Kim","year":"2011","unstructured":"Kim JY, Chun S, Bang MS, Shin H-I, Lee S-U. Safety of low-dose oral dantrolene sodium on hepatic function. Arch Phys Med Rehabil. 2011;92(9):1359\u201363.","journal-title":"Arch Phys Med Rehabil"},{"issue":"4","key":"1993_CR75","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s00125-009-1270-6","volume":"52","author":"M Akiyama","year":"2009","unstructured":"Akiyama M, Hatanaka M, Ohta Y, Ueda K, Yanai A, Uehara Y, et al. Increased insulin demand promotes while pioglitazone prevents pancreatic beta cell apoptosis in Wfs1 knockout mice. Diabetologia. 2009;52(4):653\u201363.","journal-title":"Diabetologia"},{"issue":"3","key":"1993_CR76","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1210\/en.2013-1519","volume":"155","author":"T Hara","year":"2014","unstructured":"Hara T, Mahadevan J, Kanekura K, Hara M, Lu S, Urano F. Calcium efflux from the endoplasmic reticulum leads to \u03b2-cell death. Endocrinology. 2014;155(3):758\u201368.","journal-title":"Endocrinology"},{"issue":"4","key":"1993_CR77","doi-asserted-by":"publisher","first-page":"916","DOI":"10.2337\/dc10-1068","volume":"34","author":"JD Lewis","year":"2011","unstructured":"Lewis JD, Ferrara A, Peng T, Hedderson M, Bilker WB, Quesenberry CP, et al. Risk of bladder cancer among diabetic patients treated with pioglitazone: interim report of a longitudinal cohort study. Diabetes Care. 2011;34(4):916\u201322.","journal-title":"Diabetes Care"},{"issue":"14","key":"1993_CR78","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1001\/archinternmed.2010.207","volume":"170","author":"SE Nissen","year":"2010","unstructured":"Nissen SE, Wolski K. Rosiglitazone revisited: an updated meta-analysis of risk for myocardial infarction and cardiovascular mortality. Arch Intern Med. 2010;170(14):1191\u2013201.","journal-title":"Arch Intern Med"},{"key":"1993_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcjd.2018.06.007","author":"M Toots","year":"2018","unstructured":"Toots M, Reimets R, Plaas M, Vasar E. Muscarinic agonist ameliorates insulin secretion in Wfs1-deficient mice. Can J diabetes. 2018. \n                    https:\/\/doi.org\/10.1016\/j.jcjd.2018.06.007\n                    \n                  .","journal-title":"Can J diabetes"},{"issue":"8","key":"1993_CR80","doi-asserted-by":"publisher","first-page":"2714","DOI":"10.2337\/db13-1371","volume":"63","author":"J Molina","year":"2014","unstructured":"Molina J, Rodriguez-Diaz R, Fachado A, Jacques-Silva MC, Berggren P-O, Caicedo A. Control of insulin secretion by cholinergic signaling in the human pancreatic islet. Diabetes. 2014;63(8):2714\u201326.","journal-title":"Diabetes"},{"issue":"10","key":"1993_CR81","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1007\/s00125-018-4679-y","volume":"61","author":"M Kondo","year":"2018","unstructured":"Kondo M, Tanabe K, Amo-Shiinoki K, Hatanaka M, Morii T, Takahashi H, et al. Activation of GLP-1 receptor signalling alleviates cellular stresses and improves beta cell function in a mouse model of Wolfram syndrome. Diabetologia. 2018;61(10):2189\u2013201.","journal-title":"Diabetologia"},{"issue":"10","key":"1993_CR82","doi-asserted-by":"publisher","first-page":"3592","DOI":"10.1210\/jc.2016-2240","volume":"101","author":"L Danielpur","year":"2016","unstructured":"Danielpur L, Sohn Y-S, Karmi O, Fogel C, Zinger A, Abu-Libdeh A, et al. GLP-1-RA corrects mitochondrial labile iron accumulation and improves \u03b2-cell function in type 2 Wolfram syndrome. J Clin Endocrinol Metab. 2016;101(10):3592\u20139.","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"1993_CR83","doi-asserted-by":"publisher","first-page":"871","DOI":"10.2165\/11635890-000000000-00000","volume":"26","author":"C H\u00f6lscher","year":"2012","unstructured":"H\u00f6lscher C. Potential role of glucagon-like peptide-1 (GLP-1) in neuroprotection. CNS Drugs. 2012;26(10):871\u201382.","journal-title":"CNS Drugs"},{"issue":"19","key":"1993_CR84","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","volume":"375","author":"SP Marso","year":"2016","unstructured":"Marso SP, Bain SC, Consoli A, Eliaschewitz FG, J\u00f3dar E, Leiter LA, et al. Semaglutide and cardiovascular outcomes in patients with type 2 diabetes. N Engl J Med. 2016;375(19):1834\u201344.","journal-title":"N Engl J Med"},{"issue":"4","key":"1993_CR85","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1056\/NEJMoa1603827","volume":"375","author":"SP Marso","year":"2016","unstructured":"Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JFE, Nauck MA, et al. Liraglutide and cardiovascular outcomes in type 2 diabetes. N Engl J Med. 2016;375(4):311\u201322.","journal-title":"N Engl J Med"},{"issue":"6","key":"1993_CR86","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.2337\/db16-1364","volume":"66","author":"R Sim\u00f3","year":"2017","unstructured":"Sim\u00f3 R, Hern\u00e1ndez C. GLP-1R as a target for the treatment of diabetic retinopathy: friend or foe? Diabetes. 2017;66(6):1453\u201360.","journal-title":"Diabetes"},{"issue":"5711","key":"1993_CR87","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1126\/science.1101902","volume":"307","author":"M Boyce","year":"2005","unstructured":"Boyce M, Bryant KF, Jousse C, Long K, Harding HP, Scheuner D, et al. A selective inhibitor of eIF2\u03b1 dephosphorylation protects cells from ER stress. Science (80-). 2005;307(5711):935\u20139.","journal-title":"Science (80-)"},{"issue":"6","key":"1993_CR88","doi-asserted-by":"publisher","first-page":"3989","DOI":"10.1074\/jbc.M607627200","volume":"282","author":"M Cnop","year":"2007","unstructured":"Cnop M, Ladriere L, Hekerman P, Ortis F, Cardozo AK, Dogusan Z, et al. Selective inhibition of eukaryotic translation initiation factor 2\u03b1 dephosphorylation potentiates fatty acid-induced endoplasmic reticulum stress and causes pancreatic \u03b2-cell dysfunction and apoptosis. J Biol Chem. 2007;282(6):3989\u201397.","journal-title":"J Biol Chem"},{"issue":"1","key":"1993_CR89","doi-asserted-by":"publisher","first-page":"e4134","DOI":"10.1371\/journal.pone.0004134","volume":"4","author":"C Kakiuchi","year":"2009","unstructured":"Kakiuchi C, Ishigaki S, Oslowski CM, Fonseca SG, Kato T, Urano F. Valproate, a mood stabilizer, induces WFS1 expression and modulates its interaction with ER stress protein GRP94. PLoS ONE. 2009;4(1):e4134.","journal-title":"PLoS ONE"},{"issue":"2","key":"1993_CR90","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3390\/ijms18020315","volume":"18","author":"Z Li","year":"2017","unstructured":"Li Z, Wu F, Zhang X, Chai Y, Chen D, Yang Y, et al. Valproate attenuates endoplasmic reticulum stress-induced apoptosis in SH-SY5Y cells via the AKT\/GSK3\u03b2 signaling pathway. Int J Mol Sci. 2017;18(2):315.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1993_CR91","doi-asserted-by":"publisher","first-page":"661","DOI":"10.3892\/mmr.2015.4580","volume":"13","author":"X Sun","year":"2016","unstructured":"Sun X, Qin H, Zhang Z, Xu Y, Yang X, Zhao D, et al. Valproate attenuates diabetic nephropathy through inhibition of endoplasmic reticulum stress-induced apoptosis. Mol Med Rep. 2016;13(1):661\u20138.","journal-title":"Mol Med Rep"},{"issue":"1","key":"1993_CR92","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.exer.2011.11.013","volume":"94","author":"Z Zhang","year":"2012","unstructured":"Zhang Z, Qin X, Tong N, Zhao X, Gong Y, Shi Y, et al. Valproic acid-mediated neuroprotection in retinal ischemia injury via histone deacetylase inhibition and transcriptional activation. Exp Eye Res. 2012;94(1):98\u2013108.","journal-title":"Exp Eye Res"},{"issue":"2","key":"1993_CR93","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.neulet.2011.09.003","volume":"504","author":"Z Zhang","year":"2011","unstructured":"Zhang Z, Tong N, Gong Y, Qiu Q, Yin L, Lv X, et al. Valproate protects the retina from endoplasmic reticulum stress-induced apoptosis after ischemia\u2013reperfusion injury. Neurosci Lett. 2011;504(2):88\u201392.","journal-title":"Neurosci Lett"},{"key":"1993_CR94","unstructured":"European Medicines Agency. Public summary of opinion on orphan designation. Sodium valproate for the treatment of Wolfram Syndromeo Title; 2015."},{"key":"1993_CR95","doi-asserted-by":"publisher","DOI":"10.1111\/J.1755-3768.2017.03174","author":"C Hamel","year":"2017","unstructured":"Hamel C, Jagodzinska J, Bonner-Wersinger D, Koks S, Seveno M, Delettre C. Advances in gene therapy for Wolfram syndrome. Acta Ophthalmol. 2017. \n                    https:\/\/doi.org\/10.1111\/J.1755-3768.2017.03174\n                    \n                  .","journal-title":"Acta Ophthalmol"},{"issue":"2","key":"1993_CR96","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.celrep.2014.03.023","volume":"7","author":"M Lindahl","year":"2014","unstructured":"Lindahl M, Danilova T, Palm E, Lindholm P, Voikar V, Hakonen E, et al. MANF is indispensable for the proliferation and survival of pancreatic beta cells. Cell Rep. 2014;7(2):366\u201375.","journal-title":"Cell Rep"},{"issue":"2","key":"1993_CR97","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1385\/JMN:20:2:173","volume":"20","author":"PS Petrova","year":"2003","unstructured":"Petrova PS, Raibekas A, Pevsner J, Vigo N, Anafi M, Moore MK, et al. MANF. J Mol Neurosci. 2003;20(2):173\u201387.","journal-title":"J Mol Neurosci"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-019-1993-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12967-019-1993-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-019-1993-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T23:15:12Z","timestamp":1595373312000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-019-1993-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,23]]},"references-count":97,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1993"],"URL":"https:\/\/doi.org\/10.1186\/s12967-019-1993-1","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,23]]},"assertion":[{"value":"22 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All the studies mentioned in this review were approved by the Ethics Committee, and written informed consent was obtained by all the participants.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"238"}}